基于AGREEII对中医治疗抑郁症指南质量评价及脏腑辨证研究
Based on AGREEII,the quality evaluation of TCM treatment guidelines for depression and syndrome differentiation of zang-fu organs were studied
张路辉 1朱师佳 1陶玉慧2
作者信息
- 1. 江西中医药大学研究生院,南昌 330004
- 2. 江西中医药大学附属医院,南昌 330006
- 折叠
摘要
目的 客观地评价中医药治疗抑郁症的疗效及安全性,探讨中医脏腑辨证理论在抑郁症中的运用.方法 采用指南研究与评估工具(AGREEII)评价CPGS/共识方法学质量,从中医药手段、辨证分型治疗抑郁症方面,进行系统梳理中医推荐意见及证据强度.结果 共纳入 5 项(CPGS/共识),AGREEII各领域标准化平均得分为 77.8%(范围和目的)、45.8%(参与人员)、42.9%(严谨性)、61.1%(清晰性)、30.8%(应用性)和 52.8%(编辑独立性).结论 中医药治疗抑郁症(CPGS/共识)的总体质量偏低,参与者、制定的严谨性、应用性、编辑的独立性有待提高,指南涉及的诊疗内容较为全面,但缺乏证据支持,指南提出需要进一步完善和优化临床实践.
Abstract
Objective To objectively evaluate the efficacy and safety of traditional Chinese medicine(TCM)in the treatment of depression,and to explore the application of TCM zangfu syndrome differentiation theory in depression.Methods The quality of CPGS/consensus methodology was evaluated by the guidebook research and evaluation tool(AGREEII),and the recommendations and evidence intensity were systematically combed from the aspects of traditional Chinese medicine(TCM)approach and syndrome differentiation for depression.Results With a total of 5(CPGS/Consensus)included,the AGREEII standardized average score across all areas was 77.8%(scope and purpose),45.8%(participants),42.9%(rigor),61.1%(clarity),30.8%(application)and 52.8%(editorial independence).Conclusion The overall quality of CPGS/Consensus in the treatment of depression in Chi-nese medicine(CPGS/Consensus)is low,and the participants,rigor of development,application,and editorial independence need to be improved.The guidelines are comprehensive in their approach to diagnosis and treatment,but lack evidence to support them.
关键词
抑郁症/中医药/指南/质量评价Key words
Depression/Chinese medicine/Guideline/Quality assessment引用本文复制引用
基金项目
江西省卫生健康委科技计划(202210747)
出版年
2024
NETL
NSTL
万方数据